BOSTON SCIENTIFIC CORP — Director's Dealing 2024

Feb 20, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2024-02-18

Reporting Person: Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-18	Common Stock	M	2002.0000	$0.0000	Acquired	31203.9900	Direct
2024-02-18	Common Stock	F	1160.0000	$65.8200	Disposed	30043.9900	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-18	Deferred Stock Units	$	M	2002.0000	Disposed	2024-02-18	Common Stock (2002.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.